Article content continued

One example of that creativity was on display Wednesday when CannTrust Holdings, a licensed producer of medicinal cannabis, announced a $15 million bought deal: 3 million shares at $5 a share.

The financing is not the most striking part of the company, which in August filed a prospectus to qualify the distribution of 12.6 million special warrants (each priced at $2) placed earlier in the year.

What’s novel about CannTrust, which received its Health Canada licence in mid-2014, is how it has tried to diversify its product range. And the big breakthrough occurred two years back when it formed a partnership with Toronto-based Club Coffee L.P., which has been around since 1906.

That partnership is known as the Cannabis Coffee & Tea Pod Company Ltd., and it produces a product called BrewBudz, which it planned to launch in the U.S., and elsewhere, but not in Canada. In its recent MD&A, the company said BrewBudz “is a U.S. patented unit dose pod formulation allowing the administration of cannabis using single-serve brewing pods for use in Keurig, Nespresso, and Tassimo type brewers.”

In other words, to quote the waiter, “would you like a little tonic with your morning Java?”

And who could resist if it also cures a little hangover.

The company is not there yet — but the potential exists.

Through the partnership, CannTrust will receive royalty income from a licensing agreement that currently covers six states (Washington, Oregon, California, Nevada, Arizona and Colorado.) Initial sales are expected to start shortly in Nevada. Calls to CannTrust were not returned.